Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Sample type	Gender
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	10479	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	23409	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	25268	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	32707	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	32987	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	38577	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	38934	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	41215	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	41926	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	43669	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	44114	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	44454	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	45974	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	50145	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	51547	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	51726	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	52432	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	54262	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	54834	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	55057	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	55398	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	55601	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	56126	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	57799	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	58608	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	58989	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	65515	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	69983	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	75351	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	75594	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	75809	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	76359	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	79931	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	80911	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	82699	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	84349	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	85696	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	85951	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	87499	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	87737	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	88528	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	92649	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	94255	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	94784	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	95498	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	100470	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	100598	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	101532	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	102929	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	105456	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	106434	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	107358	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	107650	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	107966	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	108256	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	109208	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	111004	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	113112	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	113133	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	114557	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	115778	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	119639	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	123488	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	124034	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	128404	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	130812	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	132633	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	136370	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	137812	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	138965	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	145919	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	147346	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	147660	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	148386	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	155014	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	155621	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	156941	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	169060	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	169428	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	169635	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	173376	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	174889	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	177314	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	180385	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	191389	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	191728	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	192698	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	194282	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	195590	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	197494	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	203497	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	207978	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	208934	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	217539	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	226535	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	227754	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	243806	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	250935	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	254582	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	255217	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	279888	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	290821	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	294957	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	296559	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	297754	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	298949	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	300551	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	303454	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	303593	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	306393	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	306538	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	308933	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	309792	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	312396	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	314106	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	315215	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	315815	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	317189	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	317474	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	317677	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	318891	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	320221	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	320253	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	320308	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	321468	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	321683	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	322572	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	323015	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	323103	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	326399	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	330947	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	336342	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	340660	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	342012	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	346455	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	351023	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	357709	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	359789	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	362030	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	362041	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	367937	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	370070	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	372488	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	373029	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	374380	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	374610	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	374706	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	374827	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	376254	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	377019	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	377056	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	377487	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	377632	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	378139	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	378368	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	378518	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	378696	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	379002	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	379106	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	379391	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	379394	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	379505	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	379518	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	379911	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	379978	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	380077	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	380243	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	380418	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	380649	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	380778	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	380817	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	380848	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	381030	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	381075	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	381221	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	381314	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	381456	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	381580	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	381650	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	381688	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	381748	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	382135	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	382291	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	382805	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	383042	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	383792	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	384404	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	384541	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	384627	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	385246	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	385668	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	386400	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	387482	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	387484	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	388201	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	388409	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	393453	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	394011	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	397928	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	glycoursodeoxycholate	401563	Peak area normalized	Sample	male

Return to search page